Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes
Clinical trial NCT04861207 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04861207
- Sponsor
- Maria Sklodowska-Curie National Research Institute of Oncology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-07
- Primary completion
- 2027-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.